Debenture Agreements in the Biotechnology Industry

99 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Convertible Bond Acquisition Agreement between KC Creation Co Ltd and Exicure, Inc. dated April 30, 2025
Debenture Agreements
EXICURE, INC.
Biotechnology
2025
Senior Secured Convertible Debenture Agreement between PDS Biotechnology Corporation and Holder
Debenture Agreements
Edge Therapeutics, Inc.
Biotechnology
NY
2025
Debenture Creating Fixed and Floating Charges between KalVista Pharmaceuticals Limited and DRI Healthcare Acquisitions LP (November 4, 2024)
Debenture Agreements
KalVista Pharmaceuticals, Inc.
Biotechnology
NY
2025
Amendment to Non-Convertible Debenture between Onconetix, Inc. and Altos Venture AG dated April 24, 2024
Debenture Agreements
Blue Water Vaccines Inc.
Biotechnology
2024
8% Convertible Debenture Agreement between Qualigen Therapeutics, Inc. and Yi Hua Chen (April 2024)
Debenture Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
DE
2024
8% Convertible Debenture Agreement between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (February 2024)
Debenture Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
DE
2024
Non-Convertible Debenture Agreement between Onconetix, Inc. and Altos Venture AG dated January 23, 2024
Debenture Agreements
Blue Water Vaccines Inc.
Biotechnology
NY
2024
8% Senior Convertible Debenture Agreement between Qualigen Therapeutics, Inc. and Alpha Capital Anstalt (Due December 22, 2025)
Debenture Agreements
RITTER PHARMACEUTICALS INC
Biotechnology
NY
2022
Theralink Technologies, Inc. 10.0% Original Issue Discount Senior Secured Convertible Debenture Due November 29, 2023
Debenture Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Theralink Technologies, Inc. 10.0% Original Issue Discount Senior Secured Convertible Debenture Due 2023
Debenture Agreements
OncBioMune Pharmaceuticals, Inc
Biotechnology
NV
2022
Fifth Amendment to 8% Convertible Debenture between Qrons Inc. and CubeSquare LLC
Debenture Agreements
Qrons Inc.
Biotechnology
2021
Fourth Amendment to $15,000 8% Convertible Debenture between Qrons Inc. and CubeSquare LLC
Debenture Agreements
Qrons Inc.
Biotechnology
2021
Senior Convertible Debenture Agreement between Inspyr Therapeutics, Inc. and Holder (June 18, 2021)
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2021
Q BioMed Inc. $500,000 Convertible Debenture Agreement with YA II PN, Ltd. dated February 12, 2021
Debenture Agreements
Q BioMed Inc.
Biotechnology
2021
Senior Convertible Debenture Agreement between Inspyr Therapeutics, Inc. and Holder (January 2021)
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2021
Q BioMed Inc. $500,000 Convertible Debenture Agreement with YA II PN, Ltd. (December 23, 2020)
Debenture Agreements
Q BioMed Inc.
Biotechnology
2020
Senior Convertible Debenture Agreement between Inspyr Therapeutics, Inc. and Holder (Due October 23, 2021)
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2020
Vaccinex, Inc. 7% Original Issue Discount Senior Secured Convertible Debenture Due August 3, 2021 (with 3i, LP)
Debenture Agreements
VACCINEX, INC.
Biotechnology
NY
2020
Vaccinex, Inc. and 3i, LP 7% Original Issue Discount Senior Secured Convertible Debenture Agreement (Due August 3, 2021)
Debenture Agreements
VACCINEX, INC.
Biotechnology
NY
2020
GeoVax Labs, Inc. 5% Original Issue Discount Senior Secured Convertible Debenture Agreement (2020-2021)
Debenture Agreements
GeoVax Labs, Inc.
Biotechnology
NY
2020
8% Convertible Debenture between Bioxytran, Inc. and Power Up Lending Group Ltd. dated March 18, 2020
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
Senior Convertible Debenture Agreement between Inspyr Therapeutics, Inc. and Holder (March 6, 2020)
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2020
8% Convertible Debenture Agreement between Bioxytran, Inc. and Power Up Lending Group Ltd. dated February 18, 2020
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NY
2020
Q BioMed Inc. Convertible Debenture Agreement with YA II PN, Ltd.
Debenture Agreements
Q BioMed Inc.
Biotechnology
2019
Convertible Debenture Agreement between Bioxytran, Inc. and Peak One Opportunity Fund, L.P. dated October 22, 2019
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NV
2019
8% Convertible Debenture Agreement between Bioxytran, Inc. and Peak One Opportunity Fund, L.P. dated October 22, 2019
Debenture Agreements
BIOXYTRAN, INC
Biotechnology
NV
2019
Q BioMed Inc. $500,000 Convertible Debenture Agreement with YA II PN, Ltd. (October 11, 2019)
Debenture Agreements
Q BioMed Inc.
Biotechnology
2019
BioVie Inc. 10% OID Convertible Delayed Draw Debenture Agreement with Acuitas Group Holdings, LLC
Debenture Agreements
BIOVIE INC.
Biotechnology
NY
2019
Mateon Therapeutics, Inc. Convertible Debenture Due April 2022
Debenture Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Mateon Therapeutics, Inc. $200,000 Convertible Debenture Due April 2022 with Peak One Opportunity Fund, L.P.
Debenture Agreements
MATEON THERAPEUTICS INC
Biotechnology
DE
2019
Amendment to 8% Secured Debentures between Chanticleer Holdings, Inc. and Debenture Holders
Debenture Agreements
Chanticleer Holdings, Inc.
Biotechnology
2019
Second Amendment to 8% Convertible Debenture between Qrons Inc. and CubeSquare LLC
Debenture Agreements
Qrons Inc.
Biotechnology
2019
First Amendment to 8% Convertible Debenture between Qrons Inc. and CubeSquare LLC
Debenture Agreements
Qrons Inc.
Biotechnology
2019
2018 6% Convertible Debenture Agreement between Organicell Regenerative Medicine, Inc. and Debenture Holder
Debenture Agreements
Organicell Regenerative Medicine, Inc.
Biotechnology
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due September 24, 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Q BioMed Inc. $2,000,000 Convertible Debenture Agreement with YA II PN, Ltd. (September 21, 2018)
Debenture Agreements
Q BioMed Inc.
Biotechnology
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
GT Biopharma, Inc. 10% Senior Convertible Debenture Due August 2, 2019
Debenture Agreements
GT Biopharma, Inc.
Biotechnology
NY
2018
Senior Convertible Debenture Agreement between Inspyr Therapeutics, Inc. and Holder (July 2018)
Debenture Agreements
Inspyr Therapeutics, Inc.
Biotechnology
NY
2018
Immune Pharmaceuticals Inc. Senior Secured Redeemable Convertible Debenture Agreement
Debenture Agreements
IMMUNE PHARMACEUTICALS INC
Biotechnology
2018